Press Release Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency Aug 10
Press Release Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins Jul 16